Research

Medical Sciences

Title :

Screening lead molecules identified by structure-based rational drug design methods against cytochrome b5 reductase 3 and dopamine beta hydroxylase in spontaneously hypertensive rat models for antihypertensive effects

Area of research :

Life Sciences & Biotechnology, Medical Sciences, Pharmaceutical Sciences

Focus area :

Rational drug designing for hypertensive rat models

Principal Investigator :

Prof. Suman Kundu, Professor, South Campus, Delhi University (DU), New Delhi, Prof. C C Kartha, Professor, Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram

Timeline Start Year :

2017

Timeline End Year :

2020

Contact info :

Details

Total Budget (INR):

 87,52,800

Organizations involved

Implementing Agency :

South Campus, Delhi University (DU), New Delhi
Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram

Funding Agency :

Department of Biotechnology (DBT), Government of Inida

Related Research

A Novel Therapeutic Against Metabolic Syndrome Via Activation of Coagulation Unrelated Vitamin K Dependent Proteins
A randomized, Double-blind, Placebo and Active controlled, Multicenter, Phase 3 Study to Access the Efficacy and Safety of Filgotinib Administered for 52 Weeks Alone and in Combination with Methotrexate (MTX) to Subjects with Moderately to Severely Active Rheumatoid Arthritis who Are Naive to MTX Therapy
Advanced Animal Diagnostics and Management Consortium (ADMaC)
An event-driven, phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficiency, safety, immunogenicity, & lot-to-lot consistency of Bbv152, a whole-varion inactivated Sars-Cov-2 vaccine in adults more than 18 to years of age
An integrated approach to the treatment of duchenne muscular dystrophy and spinal muscular atrophy